1. Home
  2. VCTR vs AAPG Comparison

VCTR vs AAPG Comparison

Compare VCTR & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCTR
  • AAPG
  • Stock Information
  • Founded
  • VCTR 2013
  • AAPG 2009
  • Country
  • VCTR United States
  • AAPG China
  • Employees
  • VCTR N/A
  • AAPG N/A
  • Industry
  • VCTR Investment Managers
  • AAPG Biotechnology: Pharmaceutical Preparations
  • Sector
  • VCTR Finance
  • AAPG Health Care
  • Exchange
  • VCTR Nasdaq
  • AAPG Nasdaq
  • Market Cap
  • VCTR 4.3B
  • AAPG 3.6B
  • IPO Year
  • VCTR 2018
  • AAPG 2025
  • Fundamental
  • Price
  • VCTR $71.26
  • AAPG $45.00
  • Analyst Decision
  • VCTR Buy
  • AAPG Buy
  • Analyst Count
  • VCTR 10
  • AAPG 1
  • Target Price
  • VCTR $71.40
  • AAPG N/A
  • AVG Volume (30 Days)
  • VCTR 596.0K
  • AAPG 7.2K
  • Earning Date
  • VCTR 08-07-2025
  • AAPG 08-20-2025
  • Dividend Yield
  • VCTR 2.75%
  • AAPG N/A
  • EPS Growth
  • VCTR 12.49
  • AAPG N/A
  • EPS
  • VCTR 4.00
  • AAPG N/A
  • Revenue
  • VCTR $1,028,813,000.00
  • AAPG $134,352,180.00
  • Revenue This Year
  • VCTR $44.72
  • AAPG N/A
  • Revenue Next Year
  • VCTR $15.93
  • AAPG $404.41
  • P/E Ratio
  • VCTR $17.81
  • AAPG N/A
  • Revenue Growth
  • VCTR 20.90
  • AAPG 341.77
  • 52 Week Low
  • VCTR $47.00
  • AAPG $16.50
  • 52 Week High
  • VCTR $73.42
  • AAPG $45.40
  • Technical
  • Relative Strength Index (RSI)
  • VCTR 58.41
  • AAPG N/A
  • Support Level
  • VCTR $70.58
  • AAPG N/A
  • Resistance Level
  • VCTR $72.98
  • AAPG N/A
  • Average True Range (ATR)
  • VCTR 2.06
  • AAPG 0.00
  • MACD
  • VCTR 0.06
  • AAPG 0.00
  • Stochastic Oscillator
  • VCTR 77.42
  • AAPG 0.00

About VCTR Victory Capital Holdings Inc.

Victory Capital Holdings Inc is an independent investment management firm. The company operates its business through franchises and solutions platform. It provides centralized distribution, marketing, and operations infrastructure to the company's franchises and solutions platform. The company operates through one business segment that is Investment management services and products to institutional, intermediary, retirement platforms, and individual investors. The franchises and solutions platform manages a variety of investment strategies for its customers. It derives majority of its revenues from asset-based fees from investment management products and services to individuals and institutions.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: